Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Research|August 3, 2007
Lysis of dysplastic but not normal oral keratinocytes and tissue-engineered epithelia with conditionally replicating adenovirusesKamis Gaballah, Allison Hills, David Curiel, et al.
Cytotherapy|October 13, 2020
An assessment of the hospital exemption landscape across European Member States: regulatory frameworks, use and impactAllison Hills, Jacquelyn Awigena-Cook, Ken Genenz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal marginsXiaohong Huang, Stelios Pateromichelakis, Allison Hills, et al.
Cancer Metastasis Reviews|October 31, 2012
Hide and seek: tell-tale signs of breast cancer lurking in the bloodDavid S Guttery, Kevin Blighe, Karen Page, et al.
Cancer Research|April 20, 2013
Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinomaDaniela Elena Costea, Allison Hills, Amani H Osman, et al.
Clinical Chemistry|May 17, 2015
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancerDavid S Guttery, Karen Page, Allison Hills, et al.
Plos One|November 9, 2013
Influence of plasma processing on recovery and analysis of circulating nucleic acidsKaren Page, David S Guttery, Nathalie Zahra, et al.
Clinical Chemistry|December 13, 2016
Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast CancerKaren Page, David S Guttery, Daniel Fernandez-Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell CountsJacqueline A Shaw, David S Guttery, Allison Hills, et al.
Breast Cancer Research : BCR|December 21, 2019
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancerDaniel Fernandez-Garcia, Allison Hills, Karen Page, et al.
Pageof 2